The Equine Herpesvirus 1 U S 2 Homolog Encodes a Nonessential Membrane-Associated Virion Component

Abstract

Experiments were conducted to analyze the equine herpesvirus 1 (EHV-1) gene 68 product which is encoded by the EHV-1 U S 2 homolog. An antiserum directed against the amino-terminal 206 amino acids of the EHV-1 U S 2 protein specifically detected a protein with an M r of 34,000 in cells infected with EHV-1 strain RacL11. EHV-1 strain Ab4 encodes a 44,000- M r U s 2 protein, whereas vaccine strain RacH, a high-passage derivative of RacL11, encodes a 31,000- M r U s 2 polypeptide. Irrespective of its size, the U S 2 protein was incorporated into virions. The EHV-1 U S 2 protein localized to membrane and nuclear fractions of RacL11-infected cells and to the envelope fraction of purified virions. To monitor intracellular trafficking of the protein, the green fluorescent protein (GFP) was fused to the carboxy terminus of the EHV-1 U S 2 protein or to a truncated U S 2 protein lacking a stretch of 16 hydrophobic amino acids at the extreme amino terminus. Both fusion proteins were detected at the plasma membrane and accumulated in the vicinity of nuclei of transfected cells. However, trafficking of either GFP fusion protein through the secretory pathway could not be demonstrated, and the EHV-1 U S 2 protein lacked detectable N- and O-linked carbohydrates. Consistent with the presence of the U S 2 protein in the viral envelope and plasma membrane of infected cells, a U S 2-negative RacL11 mutant (L11ΔU S 2) exhibited delayed penetration kinetics and produced smaller plaques compared with either wild-type RacL11 or a U S 2-repaired virus. After infection of BALB/c mice with L11ΔU S 2, reduced pathogenicity compared with the parental RacL11 virus and the repaired virus was observed. It is concluded that the EHV-1 U S 2 protein modulates virus entry and cell-to-cell spread and appears to support sustained EHV-1 replication in vivo.